Total Voting Rights | 01-May-2024 | 13:11 | RNS |
Directorate Change | 30-Apr-2024 | 14:03 | RNS |
Result of AGM | 25-Apr-2024 | 14:09 | RNS |
Q1 Trading Statement | 25-Apr-2024 | 07:00 | RNS |
Total Voting Rights | 02-Apr-2024 | 13:49 | RNS |
Director/PDMR Shareholding | 28-Mar-2024 | 12:53 | RNS |
Director/PDMR Shareholding | 25-Mar-2024 | 16:47 | RNS |
Annual Report 2023 and Notice of AGM 2024 | 25-Mar-2024 | 14:07 | RNS |
Director/PDMR Shareholding | 12-Mar-2024 | 13:38 | RNS |
Full Year Results | 12-Mar-2024 | 07:00 | RNS |
Dechra Pharmaceuticals | 11-Jan-2024 | 18:00 | RNS |
Trading Statement | 10-Jan-2024 | 07:00 | RNS |
Block listing Interim Review | 01-Dec-2023 | 16:48 | RNS |
Total Voting Rights | 01-Dec-2023 | 16:45 | RNS |
Holding(s) in Company | 17-Nov-2023 | 10:25 | RNS |
Currency | UK Pounds |
Share Price | 1,467.50p |
Change Today | -9.00p |
% Change | -0.61 % |
52 Week High | 1,485.00 |
52 Week Low | 960.40 |
Volume | 249,253 |
Shares Issued | 319.74m |
Market Cap | £4,692.22m |
RiskGrade | 168 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 3 |
Neutral | 10 |
Sell | 1 |
Strong Sell | 0 |
Total | 16 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 20-Jun-24 | 12-Oct-23 |
Paid | 12-Jul-24 | 03-Nov-23 |
Amount | 40.00p | 20.00p |
Time | Volume / Share Price |
15:34 | 2 @ 1,468.00p |
15:33 | 105 @ 1,467.50p |
15:33 | 21 @ 1,467.50p |
15:33 | 53 @ 1,467.50p |
15:33 | 117 @ 1,467.50p |
You are here: research